AI-enabled mammography systems can flag individuals at increased risk for breast cancer up to six years ahead of diagnosis, outperforming traditional risk measures.
Key Details
- 1Research published June 9 in Radiology evaluated three commercial AI-CAD systems for breast cancer prediction from mammograms.
- 2Study included 31,394 women (88,963 mammograms) from the VAI-B database covering four regions in Sweden (2008-2019).
- 3At six years before diagnosis, AI systems flagged up to 19.7% of cancers at 90% specificity.
- 4AI risk scores began rising 6-8 years prior to cancer diagnosis, with a sharper rise within the last 2-3 years.
- 5AI outperformed mammographic density as a predictor, with AUCs of 0.63-0.67 versus density's AUC of 0.57 (p < 0.001).
- 6Combining AI image analysis with genetic information is being considered for improved risk stratification.
Why It Matters
Early detection of breast cancer remains a critical challenge in radiology. Demonstrating that commercial AI can identify subtle, pre-diagnosis risk years in advance suggests major potential for AI-driven personalized screening, supplemental imaging, and improved patient outcomes.
Source
AuntMinnie
Related News
•Radiology Business
RadNet AI Tool Reduces Unnecessary Prostate Biopsies by 19%
RadNet's DeepHealth AI tool can help avoid nearly 1 in 5 prostate biopsies while maintaining high cancer detection sensitivity.
•Radiology Business
Everlywell Launches Direct-to-Consumer Mammography AI for Breast Cancer Risk
Everlywell now offers the FDA-authorized Clairity Breast AI tool for patients to assess breast cancer risk from their mammograms.
•Radiology Business
Multi-Vendor AI Adoption Delivers Efficiency Gains in Private Radiology
A large-scale European study shows that adopting multiple AI tools in private radiology practices leads to significant efficiency improvements.